Invea Therapeutics, Inc. (INAI)

Invea Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021
Net Income	-8.05	-5.75	-3.62
Depreciation & Amortization	0	0	-
Share-Based Compensation	-	0.2	0.08
Other Operating Activities	2.78	0.3	0.44
Operating Cash Flow	-5.26	-5.25	-3.09
Capital Expenditures	-0.01	-0.01	-0.01
Investing Cash Flow	-0.01	-0.01	-0.01
Share Issuance / Repurchase	-	4.87	2.66
Debt Issued / Paid	-	0.65	0.76
Financing Cash Flow	3.07	5.52	3.42
Net Cash Flow	-2.2	0.26	0.32
Free Cash Flow	-5.27	-5.26	-3.1

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).